Elanders AB
29.1.2021 07:31:41 CET | Globenewswire | Press release
Full Year 2020
- Net sales were MSEK 11,050 (11,254), which was an organic reduction of 0.1 percentage points compared to the same period last year.
- Adjusted EBITA increased to MSEK 598 (563), which was an improvement of 6 percent. The adjusted EBITA margin increased to 5.4 (5.0) percent.
- The result before tax increased to MSEK 414 (216), which was an improvement of 92 percent.
- The result after tax increased to MSEK 292 (153) or SEK 8.12 (4.19) per share.
- Operating cash flow increased to MSEK 1,783 (1,454), of which acquisitions and divestitures of operations were MSEK -30 (-5).
- Strong cash flows and improved profitability during recent quarters have contributed to bringing down the net debt / EBITDA ratio (rolling 12 months) to under 2.0.
- The Board proposes a dividend of SEK 3.10 (0) per share for 2020.
Fourth Quarter 2020
- Net sales were MSEK 2,886 (2,904). Organically net sales increased by 5.5 percentage points compared to the same period last year.
- Adjusted EBITA increased to MSEK 256 (169), which was an improvement of 51 percent. The adjusted EBITA margin increased to 8.9 (5.8) percent.
- The result before tax increased to MSEK 211 (-59).
- The result after tax increased to MSEK 156 (-44) or SEK 4.33 (-1.26) per share.
- Operating cash flow increased to MSEK 693 (374), of which acquisitions and divestitures of operations were MSEK -30 (0).
Further information can be found on Elanders' website www.elanders.com or requested via e-mail info@elanders.com.
Questions concerning this report can be addressed to:
Magnus Nilsson
President and CEO
Phone: +46 31 750 07 50
Andréas Wikner
Chief Financial Officer
Phone: +46 31 750 07 50
Elanders AB (publ)
(Company ID 556008-1621)
Flöjelbergsgatan 1 C
431 35 Mölndal, Sweden
Phone: +46 31 750 00 00
This information is information that Elanders AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 07:30 CET on 29 January 2021.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Ilkka Oyj31.3.2026 18:00:00 CEST | Press release
Ilkka Oyj: Acquisition of own shares on 31 March 2026
Iveco Group N.V.31.3.2026 18:00:00 CEST | Press release
Iveco Group publishes the Informative Document concerning the sale of its Defence business
BioPorto A/S31.3.2026 17:43:41 CEST | Press release
BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis
BioPorto A/S31.3.2026 17:43:41 CEST | Pressemeddelelse
BioPorto indsender anmodning om FDA pre‑submission for amerikansk voksenprogram for urin‑NGAL efter positiv EPACRA‑analyse af AKI‑cut‑off
Kalmar Corporation31.3.2026 17:30:00 CEST | Press release
Kalmar’s Board of Directors’ constitutive meeting 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
